To ensure patient safety, various preclinical studies evaluate a drug candidate's safety before clinical trials can begin; in addition, these evaluations often contribute to determining study endpoints. Properly identifying approaches and distributing tasks between preclinical and clinical research requires collaborating and exchanging insights, facilitated by DIA platforms and networks.
Featured Networking and Knowledge Exchange